No article text was recorded for this version.
DNA repair-mediated resistance
Version 2 of 243 papers60 conceptsfrozen 2026-10-04
Papers in this version
- Blog: BRCA1/2 alterations and reversion mutations in the area of PARP inhibitors in high grade ovarian cancer: state of the art and forthcoming challenges
- Blog: A Phase 1 dose-escalation study to evaluate safety, pharmacokinetics and pharmacodynamics of AsiDNA, a first-in-class DNA repair inhibitor, administered intravenously in patients with advanced solid tumours
- Blog: PAK6 promotes homologous-recombination to enhance chemoresistance to oxaliplatin through ATR/CHK1 signaling in gastric cancer
- Blog: circEPSTI1 promotes tumor progression and cisplatin resistance via upregulating MSH2 in cervical cancer
- Blog: Triptolide induces DNA breaks, activates caspase-3-dependent apoptosis and sensitizes B-cell lymphoma to poly(ADP-ribose) polymerase 1 and phosphoinositide 3-kinase inhibitors
- Blog: Hidden Treasures in “Ancient†Microarrays: Gene-Expression Portrays Biology and Potential Resistance Pathways of Major Lung Cancer Subtypes and Normal Tissue
- Blog: RNF126‐Mediated MRE11 Ubiquitination Activates the DNA Damage Response and Confers Resistance of Triple‐Negative Breast Cancer to Radiotherapy
- Blog: FLI1 regulates radiotherapy resistance in nasopharyngeal carcinoma through TIE1-mediated PI3K/AKT signaling pathway
- Blog: Analysis of the association between KIN17 expression and the clinical features/prognosis of epithelial ovarian cancer, and the effects of KIN17 in SKOV3 cells
- Blog: Polymerase theta inhibition impairs tumor growth and amplifies melphalan-induced DNA damage in multiple myeloma
- Blog: MMS22L Expression as a Predictive Biomarker for the Efficacy of Neoadjuvant Chemoradiotherapy in Oesophageal Squamous Cell Carcinoma
- Blog: Quantitative imaging of RAD51 expression as a marker of platinum resistance in ovarian cancer
- Blog: PARP1 rs1805407 Increases Sensitivity to PARP1 Inhibitors in Cancer Cells Suggesting an Improved Therapeutic Strategy
- Blog: Expression of miR-136 is associated with the primary cisplatin resistance of human epithelial ovarian cancer
- Blog: <i>E2F1</i> Silencing Enhances Cisplatin-induced Apoptosis and DNA Damage in Retinoblastoma: <i>CENPE</i> Overexpression as a Compensatory Mechanism
- Blog: All-trans retinoic acids induce differentiation and sensitize a radioresistant breast cancer cells to chemotherapy
- Blog: Targeting the Cdc2‐like kinase 2 for overcoming platinum resistance in ovarian cancer
- Blog: Proteomic and metabolomic signatures of rectal tumor discriminate patients with different responses to preoperative radiotherapy
- Blog: Nanoparticle-based radiosensitization strategies for improving radiation therapy
- Blog: USP25 Elevates SHLD2‐Mediated DNA Double‐Strand Break Repair and Regulates Chemoresponse in Cancer
- Blog: Personalized SO2 Prodrug for pH-Triggered Gas Enhancement in Anti-Tumor Radio-Immunotherapy
- Blog: Application of Multifunctional Metal Nanoparticles in the Treatment of Glioma
- Blog: ADAR1 enhances tumor proliferation and radioresistance in non-small cell lung cancer by interacting with Rad18
- Blog: The metabolic enzyme hexokinase 2 localizes to the nucleus in AML and normal haematopoietic stem and progenitor cells to maintain stemness
- Blog: Reprimo (RPRM) as a Potential Preventive and Therapeutic Target for Radiation-Induced Brain Injury via Multiple Mechanisms
- Blog: Enzalutamide-Resistant Progression of Castration-Resistant Prostate Cancer Is Driven via the JAK2/STAT1-Dependent Pathway
- Blog: ERCC1 protein as a guide for individualized therapy of late-stage advanced non-small cell lung cancer
- Blog: MicroRNA-21 maintains hematopoietic stem cell homeostasis through sustaining the NF-κB signaling pathway in mice
- Blog: Genome-wide CRISPR-Cas9 screening identifies CLK1 inhibition as a strategy to restore PARP inhibitor sensitivity via ERCC1 isoform switching
- Blog: Genomic Breakpoint Characterization and Transcriptome Analysis of Metastatic, Recurrent Desmoplastic Small Round Cell Tumor
- Blog: Phosphatidyl inositol-3 kinase (<i>PIK3CA</i>) E545K mutation confers cisplatin resistance and a migratory phenotype in cervical cancer cells
- Blog: DNA damage-induced paraspeckle formation enhances DNA repair and tumor radioresistance by recruiting ribosomal protein P0
- Blog: ‘Cell knife’ for cancer: the clinician’s perspective
- Blog: Radiobiological evaluation of the therapeutic effect of silver-111 for the ISOLPHARM project
- Blog: Correction: Novel Conserved Genotypes Correspond to Antibiotic Resistance Phenotypes of E. coli Clinical Isolates
- Blog: Promoter methylation of SEPT9 as a potential biomarker for early detection of cervical cancer and its overexpression predicts radioresistance
- Blog: The study of the relation of DNA repair pathway genes SNPs and the sensitivity to radiotherapy and chemotherapy of NSCLC
- Blog: Coroglaucigenin enhances the radiosensitivity of human lung cancer cells through Nrf2/ROS pathway
- Blog: Radiosensitization of Osteosarcoma Cells Using the PARP Inhibitor Olaparib Combined with X-rays or Carbon Ions
- Blog: Checkpoint kinase‑1 inhibition and etoposide exhibit a strong synergistic anticancer effect on chronic myeloid leukemia cell line K562 by impairing homologous recombination DNA damage repair
- Blog: Structural insights into inhibitor regulation of the DNA repair protein DNA-PKcs
- Blog: ATM mediates DAB2IP-deficient bladder cancer cell resistance to ionizing radiation through the p38MAPK and NF-κB signaling pathway
- Blog: The miR-193a-3p-regulated ING5 gene activates the DNA damage response pathway and inhibits multi-chemoresistance in bladder cancer
History & citation
Current · Permanent link
Cite this direction
Latest version (a living page):
@misc{lacuna_dna_repair_mediated_resistance_1e7a4f86,
title = {DNA repair-mediated resistance},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/dna-repair-mediated-resistance/rdr_1e7a4f86560f42a894029c50cd9fb51e},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-19},
}This exact version (version 2, frozen text):
@misc{lacuna_dna_repair_mediated_resistance_1e7a4f86_v2,
title = {DNA repair-mediated resistance},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/dna-repair-mediated-resistance/rdr_1e7a4f86560f42a894029c50cd9fb51e/v/2},
note = {Version 2, frozen 2026-10-04. Accessed 2026-11-19},
}